the lobsterpot< podcast

Jill Reddish and Chris Day from the GCNC talk about the upcoming Andean Hemp & Cannabis Trade Forum that they’ll be hosting in Lima, Peru this October, as we ask what exactly does the Latin American cannabis market have in store for the rest of the world?

Lennart Tacke (aka Lenny Roots), HamCan’s founder, Hamburg’s premier cannabis conference, gives us a sneak preview of what’s coming up at this year’s event on August 2 and 3, and offers a glimpse into life as Germany embraces cannabis legalisation.

David Paleschuck needs little introduction to many of us working in the cannabis industry. The seasoned marketer and author of ‘Branding Bud’ is back with a new book – ‘Cannabis vs. Marijuana: Language, Landscape, and Context’ in which he delves deeper into how we should talk about our favourite plant: and what words we should use.

Tony Pavlakis from TSRgrow, based out of Rhode Island, US, knows better than most the beneficial role that ancillary businesses play in the cannabis sector. But as Europe opens up – and the US makes plans to reschedule cannabis – what are the opportunities and challenges?

While it’s easy to overlook Belgium’s burgeoning cannabis market – especially given the power plays made by its much larger neighbours – the nation has a well established CBD flower market. We speak to Joeri Perneel, founder of Pure Support CBD and the GreenGrown chain of cannabis stores to find out what’s coming next in Belgium. 

Britain’s currently undergoing a great deal of change – especially when it comes to medical cannabis. While there’s a long way to go before the social stigma dissipates, many clinics, pharmacies, patients, and producers are coming together to push the industry forward Mike Morgan-Giles, Chief Executive, Cannabis Industry Council tells us more.

Marketing in the cannabis space ain’t for the faint-hearted. Having the best ideas, boundless energy, and fanatical enthusiasm ain’t enough – even in fully-rec markets like Canada. Paul K Lawton, award-winning strategist, former academic, and co-founder of cannabis ad agency, Sister Merci; joins us for a cultured chinwag about the current state of play.

We can’t deny that from an agricultural perspective, cannabis is a plant like any other. That means it’s subject to threats from viruses, fungi, and other potential crop contaminants. Early intervention is critical. We speak to Angel Fernandez and Ajith Anand, from MyFloraDNA to better understand how to mitigate these – and other – risks.

The latest news out of the US is that cannabis could be downgraded from a ‘harmful’ Schedule I substance to a ‘medically-beneficial’ Schedule III one. But what does this actually mean? Does it bring America closer to federal legalization? Will it make the cannabis industry an easier place to do business? Chris Day from the GCNC gives us his take on what it all means.